康恩贝(600572)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

600572 康恩贝

午间休市 08-01 11:29:56

{"stockData":{"symbol":"600572","market":"SH","secType":"STK","nameCN":"康恩贝","latestPrice":4.72,"timestamp":1754018996000,"preClose":4.65,"halted":0,"volume":24003605,"delay":0,"changeRate":0.0151,"floatShares":2515000000,"shares":2522000000,"eps":0.2363,"marketStatus":"午间休市","change":0.07,"latestTime":"08-01 11:29:56","open":4.65,"high":4.76,"low":4.64,"amount":113000000,"amplitude":0.0258,"askPrice":4.72,"askSize":3227,"bidPrice":4.71,"bidSize":1537,"shortable":0,"etf":0,"ttmEps":0.2363,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1754024400000},"marketStatusCode":3,"adr":0,"adjPreClose":4.65,"symbolType":"stock","openAndCloseTimeList":[[1754011800000,1754019000000],[1754024400000,1754031600000]],"highLimit":5.12,"lowLimit":4.19,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":2521588948,"isCdr":false,"pbRate":1.67,"roa":"--","peRate":19.974609,"roe":"2.66%","epsLYR":0.25,"committee":-0.296985,"marketValue":11902000000,"turnoverRate":0.0095,"status":0,"floatMarketCap":11870000000},"requestUrl":"/m/hq/s/600572","defaultTab":"news","newsList":[{"id":"2555007667","title":"康恩贝(600572.SH)子公司氨甲环酸片获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2555007667","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555007667?lang=zh_cn&edition=full","pubTime":"2025-07-31 16:30","pubTimestamp":1753950655,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康恩贝(600572.SH)发布公告，近日，公司全资子公司杭州康恩贝制药有限公司(“杭州康恩贝”)收到国家药品监督管理局(以下简称“国家药监局”)核准签发的规格为0.25g的氨甲环酸片《药品注册证书》。氨甲环酸片的原研厂家为日本第一三共株式会社，其在日本获批上市的氨甲环酸片有0.25g规格和0.5g规格，其中0.5g规格在中国获批上市。氨甲环酸片主要用于急性或慢性、局限性或全身性原发性纤维蛋白溶解亢进所致的各种出血;弥散性血管内凝血所致的继发性高纤溶状态。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1324137.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康恩贝(600572.SH)子公司氨甲环酸片获得药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0097","BK0012","BK0188","BK0028","BK0060","BK0239","600572"],"gpt_icon":0},{"id":"2555203102","title":"【火热】首款产品获批！康恩贝抢食160亿蓝海","url":"https://stock-news.laohu8.com/highlight/detail?id=2555203102","media":"米内网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555203102?lang=zh_cn&edition=full","pubTime":"2025-07-29 16:13","pubTimestamp":1753776809,"startTime":"0","endTime":"0","summary":"精彩内容近日，康恩贝公告称，其全资子公司杭州康恩贝申报的4类仿制药培哚普利氨氯地平片(Ⅲ)获批生产并视同过评。这是康恩贝获批的首款高血压复方制剂，米内网数据显示，2024年中国三大终端六大市场高血压复方制剂销售额超过160亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729163249a4694516&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729163249a4694516&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600572","BK0239","BK0060","BK0012","BK0028","BK0188","BK0097"],"gpt_icon":0},{"id":"2555085564","title":"养老概念盘中跳水，康恩贝平盘","url":"https://stock-news.laohu8.com/highlight/detail?id=2555085564","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555085564?lang=zh_cn&edition=full","pubTime":"2025-07-29 10:00","pubTimestamp":1753754447,"startTime":"0","endTime":"0","summary":"07月29日，养老概念盘中跳水，截至10点00分，养老概念整体指数下跌1.03%，报2453.680点。从个股上来看，该概念的成分股中，康恩贝平盘，跌幅居前。从资金上来看，截止发稿，养老概念概念主力净流入为-6.01亿，其中众生药业受到资金热捧，主力净流入2.07亿；拉长时间线来看，该板块近20日主力资金净流入-123.32亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729100047a6c6d785&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729100047a6c6d785&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","BK0012","BK0060","BK0028","BK0097","BK0188","600572"],"gpt_icon":0},{"id":"2555705748","title":"康恩贝股价微跌0.22% 子公司高血压新药获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2555705748","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555705748?lang=zh_cn&edition=full","pubTime":"2025-07-29 01:57","pubTimestamp":1753725446,"startTime":"0","endTime":"0","summary":"康恩贝7月28日股价报4.59元，较前一交易日下跌0.01元，跌幅0.22%。当日成交量为296784手，成交金额达1.37亿元。康恩贝属于中药板块，是一家集药品研发、生产、销售于一体的医药企业。7月28日公司公告显示，全资子公司杭州康恩贝制药有限公司获得国家药监局核准签发的培哚普利氨氯地平片（Ⅲ）《药品注册证书》。该药品用于治疗成人高血压，2024年国内同类药品市场规模达4.36亿元。子公司已为该药品投入研发费用约1041万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507290205159723ab63&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507290205159723ab63&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600572","BK0012","BK0097","BK0060","BK0188","BK0028","BK0239"],"gpt_icon":0},{"id":"2554724666","title":"康恩贝：子公司培哚普利氨氯地平片（Ⅲ）获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2554724666","media":"格隆汇资讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554724666?lang=zh_cn&edition=full","pubTime":"2025-07-28 16:58","pubTimestamp":1753693086,"startTime":"0","endTime":"0","summary":"格隆汇7月28日丨康恩贝(600572.SH)公布，公司全资子公司杭州康恩贝制药有限公司（称“杭州康恩贝”）收到国家药品监督管理局核准签发的培哚普利氨氯地平片（Ⅲ）《药品注册证书》，培哚普利氨氯地平片（Ⅲ）用于单药治疗不能充分控制高血压的成人患者；或者作为替代疗法适用于在相同剂量水平的培哚普利和氨氯地平联合治疗下病情得以控制的原发性高血压。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507281658289722dfb8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507281658289722dfb8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0012","BK0188","BK0060","600572","BK0028","BK0239","BK0097"],"gpt_icon":0},{"id":"2553044934","title":"康恩贝集团2025年中期工作会议召开","url":"https://stock-news.laohu8.com/highlight/detail?id=2553044934","media":"康恩贝集团","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553044934?lang=zh_cn&edition=full","pubTime":"2025-07-21 00:30","pubTimestamp":1753029019,"startTime":"0","endTime":"0","summary":"2025年7月18日，康恩贝集团2025年中期工作会议在康恩贝中心2楼多功能厅召开。会议全面总结集团及下属企业上半年经营成果，部署下半年重点工作，为集团全年目标冲刺及 “十五五” 规划布局凝聚共识、明确方向。首先，胡季强对集团及各所属企业上半年工作进行了深入点评。随后，胡季强强调了下半年相关重点工作。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721003133a6b5dc12&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721003133a6b5dc12&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0060","600572","BK0028","BK0239","BK0188","BK0012","BK0097"],"gpt_icon":0},{"id":"2552646788","title":"康恩贝退休总裁的激励计划不简单？","url":"https://stock-news.laohu8.com/highlight/detail?id=2552646788","media":"华博商业评论","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552646788?lang=zh_cn&edition=full","pubTime":"2025-07-18 15:41","pubTimestamp":1752824493,"startTime":"0","endTime":"0","summary":"2022年，康恩贝推进股票期权激励计划，罗国良作为激励对象获授100万份股票期权。2025年6月，康恩贝发布关于调整2022年股票期权激励计划行权价格的公告，这已经不是首次对该激励计划的行权价格进行调整。而康恩贝的激励计划规定，董事会聘任的高级管理人员退休但接受返聘继续在公司任职的，其因该激励计划获授的股票期权仍然按照规定条件和程序行权 。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718155318a452e3f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718155318a452e3f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0060","BK0012","BK0188","BK0097","BK0028","600572","BK0239"],"gpt_icon":0},{"id":"2551591102","title":"每周股票复盘：康恩贝（600572）完成6357.9048万股注销手续","url":"https://stock-news.laohu8.com/highlight/detail?id=2551591102","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551591102?lang=zh_cn&edition=full","pubTime":"2025-07-13 06:10","pubTimestamp":1752358222,"startTime":"0","endTime":"0","summary":"截至2025年7月11日收盘，康恩贝报收于4.53元，较上周的4.47元上涨1.34%。最终，公司在2024年7月21日前完成了6357.9048万股的回购，占总股本2.47%，回购均价为4.72元每股，总计使用资金29992.41万元。此次注销的股份数量为6357.9048万股，占公司现有总股本的2.46%。注销后，公司的股本总数将从2585167996股减少到2521588948股，注册资本也随之减少。康恩贝计划于2025年7月9日正式向中国证券登记结算有限责任公司上海分公司提交注销申请。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071300001115.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","600572","BK0012","BK0239","BK0028","BK0097","BK0188"],"gpt_icon":0},{"id":"2550299546","title":"华创医药投资观点&研究专题周周谈第134期：中药企业的创新布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2550299546","media":"华创证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550299546?lang=zh_cn&edition=full","pubTime":"2025-07-12 00:00","pubTimestamp":1752249600,"startTime":"0","endTime":"0","summary":"本周，中信医药指数上涨1.80%，跑赢沪深300指数0.98个百分点，在中信30个一级行业中排名第16位。本周涨幅前十名股票为前沿生物-U、美迪西、联环药业、康辰药业、启迪药业、华纳药厂、浩欧博、塞力医疗、福瑞股份、广生堂。本周跌幅前十名股票ST未名、神州细胞、舒泰神、一品红、海辰药业、华海药业、美诺华、永安药业、荣昌生物、创新医疗。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250712112220a445eec5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250712112220a445eec5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["399275","600572","605199","600535","BK0239","603439","600285","600436","603567","159377","600252","603858","603998","600332","600080","603896","600750","600222","600557","600129","600351","603139","600771","600566","600976","600993","600518","600594","600479","600671"],"gpt_icon":0},{"id":"2549529618","title":"康恩贝股价微涨0.22% 公司完成6358万股回购注销","url":"https://stock-news.laohu8.com/highlight/detail?id=2549529618","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549529618?lang=zh_cn&edition=full","pubTime":"2025-07-08 23:19","pubTimestamp":1751987988,"startTime":"0","endTime":"0","summary":"截至2025年7月8日收盘，康恩贝股价报4.46元，较前一交易日上涨0.01元，涨幅0.22%。当日成交量为235190手，成交金额达1.05亿元。康恩贝是一家专注于中药研发、生产和销售的企业，主要产品涵盖心脑血管、消化系统、呼吸系统等领域。根据最新公告，康恩贝已完成6358万股股份回购注销工作，占总股本的2.46%。此次注销完成后，公司总股本减少至25.22亿股，注册资本相应调整。从资金流向来看，7月8日康恩贝主力资金净流入387.02万元，占流通市值的0.03%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/08231951570827.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0060","BK0239","BK0012","BK0097","600572","BK0188","BK0028"],"gpt_icon":0},{"id":"2549342903","title":"每周股票复盘：康恩贝（600572）2025年第二季度股票期权激励计划行权结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2549342903","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549342903?lang=zh_cn&edition=full","pubTime":"2025-07-06 03:16","pubTimestamp":1751742971,"startTime":"0","endTime":"0","summary":"截至2025年7月4日收盘，康恩贝报收于4.47元，较上周的4.38元上涨2.05%。本周关注点公司公告汇总: 2025年第二季度股票期权激励计划首次授予股票期权激励对象行权49.2437万股公司公告汇总2025年第二季度，浙江康恩贝制药股份有限公司2022年股票期权激励计划首次授予股票期权激励对象行权且完成股份过户登记的股票数量合计为49.2437万股，行权股票上市流通时间为行权日后第二个交易日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070600000358.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0060","BK0097","BK0028","BK0239","BK0188","600572"],"gpt_icon":0},{"id":"2548787030","title":"康恩贝07月01日获主力加仓606.4万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548787030","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548787030?lang=zh_cn&edition=full","pubTime":"2025-07-01 15:19","pubTimestamp":1751354351,"startTime":"0","endTime":"0","summary":"07月01日, 康恩贝股价涨1.37%，报收4.44元，成交金额1.1亿元，换手率0.99%，振幅2.05%，量比1.13。康恩贝今日主力资金净流入606.4万元，上一交易日主力净流入903.1万元。|07月01日主力加仓幅度排名||#|股票简称|主力净额占比|#|N信通电子|27.67%|#|江南新材|7.93%|#|红宝丽|6.43%|#|...|...|#1252|康恩贝|0.05%|康恩贝所在的中药Ⅱ行业，今日主力净流入2.95亿元，行业排名7/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701152633a727d216&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701152633a727d216&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","BK0097","BK0012","BK0060","BK0188","BK0239","600572"],"gpt_icon":0},{"id":"2547015164","title":"中国创新药能否持续让世界买单？券商分析师最新观点","url":"https://stock-news.laohu8.com/highlight/detail?id=2547015164","media":"券商中国","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547015164?lang=zh_cn&edition=full","pubTime":"2025-06-30 23:29","pubTimestamp":1751297340,"startTime":"0","endTime":"0","summary":"医药魔方统计，2025年1—5月，中国创新药企对外授权交易总金额已达455亿美元，超过2024年上半年的交易总额，创新药出海授权交易大爆发。亮眼数据的背后，是中国创新药整体水平的强势崛起。“中国创新药产业的研发、临床与生产能力，正处于与国际一线水平接轨的初始阶段。”由于BD数据不及预期，年内大涨明显的创新药企业荣昌生物股价近期大幅回调，从而带动创新药板块整体调整。华泰柏瑞恒生创新药ETF6月中旬以来一度单周下行超过8%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630233154a7267585&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630233154a7267585&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600216","688091","688136","688222","600062","600267","600222","603259","600998","688331","600789","688319","688520","600521","603229","603567","ONC","600513","603998","605199","688131","688166","688198","600422","600881","600535","688505","688513","601607","600721","688506","600774","600572","600420","688202","159992","600380","600557","688488","688321","688073","603127","600351","600196","688117","600056","688356","688317","BK0239","601089","603707","600079","603716","688068","600200","600080","688177","603367","603087","600682","600867","688336","688235","600851","600332","603456","688181","688189","06160","600276","600645","688163","688278","603590"],"gpt_icon":0},{"id":"2546735412","title":"独家药品概念盘中跳水，新里程跌0.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546735412","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546735412?lang=zh_cn&edition=full","pubTime":"2025-06-26 09:42","pubTimestamp":1750902126,"startTime":"0","endTime":"0","summary":"06月26日，独家药品概念盘中跳水，截至09点42分，独家药品概念整体指数下跌1.01%，报908.100点。从个股上来看，该概念的成分股中，新里程跌0.88%，康恩贝、以岭药业、健民集团跌幅居前。从资金上来看，截止发稿，独家药品概念概念主力净流入为-1.07亿，其中特宝生物受到资金热捧，主力净流入592.30万；拉长时间线来看，该板块近20日主力资金净流入-22.44亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626094206978f2eb7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626094206978f2eb7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600572","BK0250","BK0209","688278","BK0096","BK0236","BK0028","BK0077","BK0188","600976","002219"],"gpt_icon":0},{"id":"2546329146","title":"XD康恩贝06月25日获主力加仓55.7万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546329146","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546329146?lang=zh_cn&edition=full","pubTime":"2025-06-25 15:19","pubTimestamp":1750835955,"startTime":"0","endTime":"0","summary":"06月25日, XD康恩贝股价涨1.15%，报收4.39元，成交金额1.2亿元，换手率1.05%，振幅1.38%，量比1.10。XD康恩贝今日主力资金净流入55.7万元，连续4日净流入，上一交易日主力净流入1033.5万元。|06月25日主力加仓幅度排名||#|股票简称|主力净额占比|#|天晟新材|11.04%|#|新力金融|7.66%|#|北方长龙|7.56%|#|...|...|#1968|XD康恩贝|0.00%|XD康恩贝所在的中药Ⅱ行业，今日主力净流出2.04亿元，行业排名38/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625161946a71ca39a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625161946a71ca39a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0060","BK0028","BK0188","BK0012","600572","BK0097","BK0239"],"gpt_icon":0},{"id":"2545976744","title":"康恩贝06月23日获主力加仓335.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545976744","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545976744?lang=zh_cn&edition=full","pubTime":"2025-06-23 15:21","pubTimestamp":1750663282,"startTime":"0","endTime":"0","summary":"06月23日, 康恩贝股价涨0.23%，报收4.45元，成交金额9599.1万元，换手率0.84%，振幅1.35%，量比0.84。康恩贝今日主力资金净流入335.8万元，上一交易日主力净流入340.6万元。该股近5个交易日下跌1.98%，主力资金累计净流出854.3万元；近20日主力资金累计净流出3619.4万元，其中净流出天数为13日。|06月23日主力加仓幅度排名||#|股票简称|主力净额占比|#|逸豪新材|8.98%|#|大为股份|7.79%|#|C新恒汇|7.30%|#|...|...|#1689|康恩贝|0.03%|康恩贝所在的中药Ⅱ行业，今日主力净流出5311万元，行业排名30/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623171153a7186aee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623171153a7186aee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600572","BK0097","BK0028","BK0060","BK0188","BK0239","BK0012"],"gpt_icon":0},{"id":"2544831154","title":"康恩贝06月19日遭主力抛售1046.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544831154","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544831154?lang=zh_cn&edition=full","pubTime":"2025-06-19 15:20","pubTimestamp":1750317613,"startTime":"0","endTime":"0","summary":"06月19日, 康恩贝股价跌0.45%，报收4.44元，成交金额1.2亿元，换手率1.02%，振幅1.79%，量比0.87。康恩贝今日主力资金净流出1046.5万元，连续3日净流出，上一交易日主力净流出35.4万元。|06月19日主力加仓幅度排名||#|股票简称|主力净额占比|#|创新医疗|9.04%|#|凯旺科技|8.35%|#|海科新源|6.34%|#|...|...|#2964|康恩贝|-0.09%|康恩贝所在的中药Ⅱ行业，今日主力净流出5.56亿元，行业排名36/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250619165223a4b238f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250619165223a4b238f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0060","BK0188","BK0239","600572","BK0012","BK0028","BK0097"],"gpt_icon":0},{"id":"2544312761","title":"仿制药一致性评价概念盘中跳水，博雅生物跌0.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544312761","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544312761?lang=zh_cn&edition=full","pubTime":"2025-06-19 13:02","pubTimestamp":1750309369,"startTime":"0","endTime":"0","summary":"06月19日，仿制药一致性评价概念盘中跳水，截至13点02分，仿制药一致性评价概念整体指数下跌2.05%，报1044.900点。从个股上来看，该概念的成分股中，博雅生物跌0.31%，康恩贝跌幅居前。从资金上来看，截止发稿，仿制药一致性评价概念主力净流入为-7.27亿，其中易明医药受到资金热捧，主力净流入5124.86万；拉长时间线来看，该板块近20日主力资金净流入-90.33亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250619130249a4b1de16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250619130249a4b1de16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0012","BK0188","BK0060","600572","300294","BK0197","BK0028","BK0239","BK0046","BK0097"],"gpt_icon":0},{"id":"2544139349","title":"幽门螺杆菌概念盘中跳水，康恩贝跌0.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544139349","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544139349?lang=zh_cn&edition=full","pubTime":"2025-06-19 11:25","pubTimestamp":1750303511,"startTime":"0","endTime":"0","summary":"06月19日，幽门螺杆菌概念盘中跳水，截至11点25分，幽门螺杆菌概念整体指数下跌2.03%，报988.830点。从个股上来看，该概念的成分股中，康恩贝跌0.22%，之江生物跌幅居前。从资金上来看，截止发稿，幽门螺杆菌概念概念主力净流入为-6.32亿，其中罗欣药业受到资金热捧，主力净流入2266.65万；拉长时间线来看，该板块近20日主力资金净流入-50.26亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506191125119522b121&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506191125119522b121&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600572","BK0097","BK0188","BK0060","BK0012","BK0028","BK0239"],"gpt_icon":0},{"id":"2544180240","title":"医药电商概念盘中跳水，益丰药房平盘","url":"https://stock-news.laohu8.com/highlight/detail?id=2544180240","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544180240?lang=zh_cn&edition=full","pubTime":"2025-06-19 10:02","pubTimestamp":1750298561,"startTime":"0","endTime":"0","summary":"06月19日，医药电商概念盘中跳水，截至10点02分，医药电商概念整体指数下跌1.01%，报1089.580点。从个股上来看，该概念的成分股中，益丰药房平盘，康恩贝跌幅居前。从资金上来看，截止发稿，医药电商概念主力净流入为-3.27亿，其中华东医药受到资金热捧，主力净流入1387.51万；拉长时间线来看，该板块近20日主力资金净流入-103.34亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506191002419785cbb4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506191002419785cbb4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","603939","BK0188","LU2488822045.USD","600572","LU2460026573.USD","LU1064131003.USD","BK0209","LU1064130708.USD","BK0060","LU2148510915.USD","BK0239","BK0097","BK0012"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1754022677362,"stockEarnings":[{"period":"1week","weight":0.0043},{"period":"1month","weight":0.0473},{"period":"3month","weight":0.0949},{"period":"6month","weight":0.0587},{"period":"1year","weight":0.1154},{"period":"ytd","weight":0.0315}],"compareEarnings":[{"period":"1week","weight":-0.009},{"period":"1month","weight":0.0334},{"period":"3month","weight":0.0897},{"period":"6month","weight":0.0992},{"period":"1year","weight":0.2159},{"period":"ytd","weight":0.0661}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江康恩贝制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"92696人(较上一季度减少2.91%)","perCapita":"27130股","listingDate":"2004-04-12","address":"浙江省金华市兰溪市康恩贝大道1号","registeredCapital":"252158万元","survey":"　　浙江康恩贝制药股份有限公司的主营业务是药品、中药饮片及大健康产品的研发、制造及销售。公司的主要产品是中成药、中药材与中药饮片、中药保健品及中药提取物。","listedPrice":8.25},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康恩贝(600572)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康恩贝(600572)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康恩贝,600572,康恩贝股票,康恩贝股票老虎,康恩贝股票老虎国际,康恩贝行情,康恩贝股票行情,康恩贝股价,康恩贝股市,康恩贝股票价格,康恩贝股票交易,康恩贝股票购买,康恩贝股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康恩贝(600572)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康恩贝(600572)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}